October 29, 20210Clinical practice guidelines on sickle cell disease stem cell transplantation by the American Society of Hematology (ASH) were published in September 2021 in Blood Advances.[1] For patients with sickle cell disease who have had an overt stroke or who have abnormal transcranial ...
Background:Sickle cell disease (SCD) is a life-limiting inherited hemoglobinopathy that results in significant complications and affects quality of life. Hematopoietic stem cell transplantation (HSCT) is currently the only curative intervention for SCD; however, guidelines are needed to inform how to ...
Sickle Cell Disease Treatment Demonstration Regional Collaboratives Program. Accessed February 21, 2020. https://www.hrsa.gov/grants/find-funding/hrsa-17-078 75. Bleich SN, Findling MG, Casey LS, et al. Discrimination in the United States: experiences of black Americans. Health Serv Res. ...
Sickle cell disease (SCD), which affects approximately 100,000 individuals in the USA and more than 3 million worldwide, is caused by mutations in the βb globin gene that result in sickle hemoglobin production. Sickle hemoglobin polymerization leads to
Sickle Cell Disease Treatment Demonstration Program. NICHQ—National Institute for Children’s Health Quality. [cited 2022 Oct 4]. Available from:https://www.nichq.org/project/sickle-cell-disease-treatment-demonstration-program Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH,...
include factor V Leiden, the prothrombin 20210A mutation, deficienciesof protein C, protein S, or antithrombin, sickle cell disease, and hyperhomocysteine... HSR Lentz - 《Current Treatment Options in Neurology》 被引量: 30发表: 2002年 Low cobalamin levels associated with sickle cell disease: Co...
The life expectancy for individuals with sickle cell disease (SCD) has greatly increased over the last 50 years. Adults with SCD experience multiple complications such as cardiopulmonary disease, strokes, and avascular necrosis that lead to limitations that geriatric populations often experience. There ...
Individuals living with sickle cell disease (SCD) commonly report impaired health-related quality of life (HRQoL). However, impacts of SCD on HRQoL and the unmet needs of SCD treatment/management are under-researched. This study characterized the impact of SCD on HRQoL and identified the unmet ...
Advances in the diagnosis and treatment of sickle cell disease 10.1186/s13045-022-01237-z View in Scopus Google Scholar 3 K.L. Hassell Population estimates of sickle cell disease in the U.S 10.1016/j.amepre.2009.12.022 View PDF View article ...
Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharm Rev. 2011;63:811–59. Article CAS PubMed Google Scholar Musicki B, Burnett AL. Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscape. ...